Cardiovascular diseases (CVD) are one of the leading causes of death worldwide with multiple factors predisposing to the condition. Takayasu arteritis is the vasculitis of large arteries like the coronary artery that is observed specifically in pregnant females. Non-steroidal and steroidal anti-inflammatory drugs, antiplatelet drugs, immunosuppressive agents, diet regulation have been conventionally used to treat Takayasu; however, complex vasculitis seeks major surgical or endovascular interventions like conventional angioplasty, stent grafting, or other complex angioplasty procedures.
Cardiologists worldwide are working on complex high-risk interventional procedures (CHIP) to combat the most challenging cardiovascular complexities. To know more about the “Management of Takayasu and High-risk Coronary Diseases” , Docplexus, in association with the Care Institute of Medical Sciences…
